<?xml version="1.0" encoding="ISO-8859-1" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<atom:link href="http://internalmedicine.osu.edu/hematology/rss.cfm" rel="self" type="application/rss+xml" />
		<title>- Internal Medicine: Division of Hematology</title>
		<description></description>
		<pubDate>Mon, 20 May 2013 09:26:04 EST</pubDate>
		<link>http://internalmedicine.osu.edu/hematology/</link>
		
			<item>
				<title>Dr. Robert Baiocchi Merging Innovations with Commercialization</title>
				<description>Dr. Robert Baiocchi Merging Innovations with Commercialization</description>
				<link>http://internalmedicine.osu.edu/hematology/article.cfm?ID=7847</link>
				<pubDate>Tue, 23 Apr 2013 12:23:19 EST</pubDate>
				<guid isPermaLink="false">sitetool-298-7847</guid>
			</item>
		
			<item>
				<title>Byrd Receives Freireich Award for Clinical Cancer Research</title>
				<description>John Byrd, MD, director of the Division of Hematology with the OSUCCC ? James, received the Emil J. Freireich Award for clinical cancer research</description>
				<link>http://internalmedicine.osu.edu/hematology/article.cfm?ID=7820</link>
				<pubDate>Wed, 10 Apr 2013 07:58:02 EST</pubDate>
				<guid isPermaLink="false">sitetool-298-7820</guid>
			</item>
		
			<item>
				<title>Frontiers' Highlight - John C. Byrd, MD</title>
				<description>AUSPICIOUS AGENT
Experimental Drug Ibrutinib Highly Active in CLL Patients</description>
				<link>http://internalmedicine.osu.edu/hematology/article.cfm?ID=7725</link>
				<pubDate>Mon, 11 Feb 2013 12:20:20 EST</pubDate>
				<guid isPermaLink="false">sitetool-298-7725</guid>
			</item>
		
			<item>
				<title>Frontiers' Highlight - Jennifer Woyach, MD</title>
				<description>AGE ANALYSIS
Older and Younger Chronic Leukemia Patients May Need
Different Therapy</description>
				<link>http://internalmedicine.osu.edu/hematology/article.cfm?ID=7724</link>
				<pubDate>Mon, 11 Feb 2013 12:17:51 EST</pubDate>
				<guid isPermaLink="false">sitetool-298-7724</guid>
			</item>
		
			<item>
				<title>Frontiers' Highlight - Steven Devine, MD</title>
				<description>LESS IS MORE
Reduced-Intensity Regimen Before BMT is Better for
Older Leukemia Patients</description>
				<link>http://internalmedicine.osu.edu/hematology/article.cfm?ID=7723</link>
				<pubDate>Mon, 11 Feb 2013 12:12:33 EST</pubDate>
				<guid isPermaLink="false">sitetool-298-7723</guid>
			</item>
		
			<item>
				<title>Dec. 8: Ohio State?s 2012 Scarlet and Gray Reception at the</title>
				<description>We look forward to meeting and collaborating with our colleagues during the 2012 ASH Annual Meeting and Exposition in Atlanta and seeing everyone at our reception on Saturday, Dec. 8, at the Omni Hotel at CNN Center, International Ballroom, 100 CNN Center... [<a href="http://internalmedicine.osu.edu/hematology/article.cfm?ID=7645">read more</a>]</description>
				<link>http://internalmedicine.osu.edu/hematology/article.cfm?ID=7645</link>
				<pubDate>Thu, 06 Dec 2012 11:18:26 EST</pubDate>
				<guid isPermaLink="false">sitetool-298-7645</guid>
			</item>
		
			<item>
				<title>Ohio State Lymphoma Specialist Elected to Prominent Scientific Advisory Board</title>
				<description>Kristie Blum, MD, an associate professor and co-director of the Lymphoma Program in the Department of Internal Medicine?s Division of Hematology at Ohio State, has been elected to the Scientific Advisory Board for the Lymphoma Research Foundation. Read mo... [<a href="http://internalmedicine.osu.edu/hematology/article.cfm?ID=7644">read more</a>]</description>
				<link>http://internalmedicine.osu.edu/hematology/article.cfm?ID=7644</link>
				<pubDate>Thu, 06 Dec 2012 11:15:20 EST</pubDate>
				<guid isPermaLink="false">sitetool-298-7644</guid>
			</item>
		
			<item>
				<title>Pelotonia 12 Brings 4-Year Total to More Tham $42 Million</title>
				<description>Pelotonia, the fourth installment of an annual grassroots bicycle tour that raises millions of dollars for cancer research at the OSUCCC ? James, has raised more than $42 million in the four years since it began in 2009. Riders and donors in Pelotonia 12 ... [<a href="http://internalmedicine.osu.edu/hematology/article.cfm?ID=7643">read more</a>]</description>
				<link>http://internalmedicine.osu.edu/hematology/article.cfm?ID=7643</link>
				<pubDate>Thu, 06 Dec 2012 11:09:26 EST</pubDate>
				<guid isPermaLink="false">sitetool-298-7643</guid>
			</item>
		
			<item>
				<title>BLOOMFIELD RECEIVES NATIONAL SCHILSKY AWARD</title>
				<description>Clara Bloomfield, MD, an international authority on leukemia and lymphoma at the OSUCCC ? James, received the 2012 Richard L. Schilsky Cancer and Leukemia Group B (CALGB) Achievement Award from the Alliance for Clinical Trials in Oncology. The award ackno... [<a href="http://internalmedicine.osu.edu/hematology/article.cfm?ID=7443">read more</a>]</description>
				<link>http://internalmedicine.osu.edu/hematology/article.cfm?ID=7443</link>
				<pubDate>Tue, 10 Jul 2012 11:25:00 EST</pubDate>
				<guid isPermaLink="false">sitetool-298-7443</guid>
			</item>
		
			<item>
				<title>CHRONIC LEUKEMIA MARKER DISTINGUISHES MORE- VS. LESS-AGGRESSIVE FORMS</title>
				<description>Researchers at the OSUCCC ? James have identified a prognostic marker in the most common form of chronic leukemia that can help to distinguish which patients should start treatment quickly from those who can safely delay treatment, perhaps for years</description>
				<link>http://internalmedicine.osu.edu/hematology/article.cfm?ID=7426</link>
				<pubDate>Mon, 02 Jul 2012 09:58:13 EST</pubDate>
				<guid isPermaLink="false">sitetool-298-7426</guid>
			</item>
		
	
	</channel>
</rss>